{"transactions":[{"id":4628430,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-10-03T01:35:06.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":1846,"price":415.0691,"value":766217.5586,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $414.44 to $415.19 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":106914,"source":{"system":"sec-edgar","filing":"0002010019-26-000030","document":"form4-10022026_091001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000030/form4-10022026_091001.xml","form_type":"4"}},{"id":4628429,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-10-03T01:35:06.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":954,"price":413.1066,"value":394103.6964,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $412.8350 to $413.3100 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":108760,"source":{"system":"sec-edgar","filing":"0002010019-26-000030","document":"form4-10022026_091001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000030/form4-10022026_091001.xml","form_type":"4"}},{"id":4628428,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-10-03T01:35:06.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":200,"price":411.62,"value":82324.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $411.55 to $411.69 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":109714,"source":{"system":"sec-edgar","filing":"0002010019-26-000030","document":"form4-10022026_091001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000030/form4-10022026_091001.xml","form_type":"4"}},{"id":4050,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-09-04T01:35:05.000Z","date":"2026-09-02","kind":"sale","planned":true,"acquired":false,"shares":15160,"price":326.894,"value":4955713.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on August 25, 2023."}],"balance_after":110859,"source":{"system":"sec-edgar","filing":"0002010019-26-000028","document":"form4-09032026_090901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000028/form4-09032026_090901.xml","form_type":"4"}},{"id":4049,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-09-04T01:35:05.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":600,"price":321.9067,"value":193144.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $321.49 to $322.11 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":126019,"source":{"system":"sec-edgar","filing":"0002010019-26-000028","document":"form4-09032026_090901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000028/form4-09032026_090901.xml","form_type":"4"}},{"id":4048,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-09-04T01:35:05.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":1400,"price":320.9225,"value":449291.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $320.36 to $321.17 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":126619,"source":{"system":"sec-edgar","filing":"0002010019-26-000028","document":"form4-09032026_090901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000028/form4-09032026_090901.xml","form_type":"4"}},{"id":4047,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-09-04T01:35:05.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":319.7582,"value":319758.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $319.2850 to $320.26 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":128019,"source":{"system":"sec-edgar","filing":"0002010019-26-000028","document":"form4-09032026_090901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000028/form4-09032026_090901.xml","form_type":"4"}},{"id":695947,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-08-06T01:35:11.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":128,"price":268.6964,"value":34393.1392,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $268.63 to $268.73 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":129019,"source":{"system":"sec-edgar","filing":"0002010019-26-000024","document":"form4-08052026_090806.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000024/form4-08052026_090806.xml","form_type":"4"}},{"id":695946,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-08-06T01:35:11.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":1233,"price":267.7869,"value":330181.2477,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $267.1550 to $268.1150 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":129147,"source":{"system":"sec-edgar","filing":"0002010019-26-000024","document":"form4-08052026_090806.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000024/form4-08052026_090806.xml","form_type":"4"}},{"id":695945,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-08-06T01:35:11.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":192,"price":265.275,"value":50932.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $265.27 to $265.28 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":130380,"source":{"system":"sec-edgar","filing":"0002010019-26-000024","document":"form4-08052026_090806.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000024/form4-08052026_090806.xml","form_type":"4"}},{"id":695944,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-08-06T01:35:11.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":947,"price":263.9415,"value":249952.6005,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $263.6550 to $264.2400 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":130572,"source":{"system":"sec-edgar","filing":"0002010019-26-000024","document":"form4-08052026_090806.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000024/form4-08052026_090806.xml","form_type":"4"}},{"id":695943,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-08-06T01:35:11.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":200,"price":261.4875,"value":52297.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $261.1500 to $261.8250 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":131519,"source":{"system":"sec-edgar","filing":"0002010019-26-000024","document":"form4-08052026_090806.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000024/form4-08052026_090806.xml","form_type":"4"}},{"id":695942,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-08-06T01:35:11.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":300,"price":259.98,"value":77994.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."}],"balance_after":131719,"source":{"system":"sec-edgar","filing":"0002010019-26-000024","document":"form4-08052026_090806.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000024/form4-08052026_090806.xml","form_type":"4"}},{"id":695941,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-08-06T01:35:11.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":410,"price":267.9893,"value":109875.613,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025."}],"balance_after":132019,"source":{"system":"sec-edgar","filing":"0002010019-26-000024","document":"form4-08052026_090806.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000024/form4-08052026_090806.xml","form_type":"4"}},{"id":701567,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-07-30T01:35:11.000Z","date":"2026-07-28","kind":"sale","planned":true,"acquired":false,"shares":1204,"price":254.0705,"value":305900.882,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $254.0696 to $254.3500 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":132429,"source":{"system":"sec-edgar","filing":"0002010019-26-000021","document":"form4-07292026_090707.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000021/form4-07292026_090707.xml","form_type":"4"}},{"id":701566,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-07-30T01:35:11.000Z","date":"2026-07-27","kind":"sale","planned":true,"acquired":false,"shares":1010,"price":260.4908,"value":263095.708,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (\"RSUs\") and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 26, 2024."}],"balance_after":133633,"source":{"system":"sec-edgar","filing":"0002010019-26-000021","document":"form4-07292026_090707.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000021/form4-07292026_090707.xml","form_type":"4"}},{"id":715702,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-07-07T01:05:05.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":300,"price":274.06,"value":82218.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."}],"balance_after":134643,"source":{"system":"sec-edgar","filing":"0002010019-26-000016","document":"form4-07062026_090701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000016/form4-07062026_090701.xml","form_type":"4"}},{"id":715701,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-07-07T01:05:05.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":2600,"price":272.99,"value":709774.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $272.74 to $273.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":134943,"source":{"system":"sec-edgar","filing":"0002010019-26-000016","document":"form4-07062026_090701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000016/form4-07062026_090701.xml","form_type":"4"}},{"id":715700,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-07-07T01:05:05.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":100,"price":267.185,"value":26718.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $267.05 to $267.30 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":137543,"source":{"system":"sec-edgar","filing":"0002010019-26-000016","document":"form4-07062026_090701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000016/form4-07062026_090701.xml","form_type":"4"}},{"id":752235,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-06-04T01:05:08.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":572,"price":220.6674,"value":126221.7528,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $220.52 to $220.83 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":137643,"source":{"system":"sec-edgar","filing":"0002010019-26-000015","document":"form4-06032026_090604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000015/form4-06032026_090604.xml","form_type":"4"}},{"id":752234,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-06-04T01:05:08.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":213,"price":219.34,"value":46719.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."}],"balance_after":138215,"source":{"system":"sec-edgar","filing":"0002010019-26-000015","document":"form4-06032026_090604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000015/form4-06032026_090604.xml","form_type":"4"}},{"id":752233,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-06-04T01:05:08.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":413,"price":218.8445,"value":90382.7785,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $218.2250 to $219.0900 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":138428,"source":{"system":"sec-edgar","filing":"0002010019-26-000015","document":"form4-06032026_090604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000015/form4-06032026_090604.xml","form_type":"4"}},{"id":752232,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-06-04T01:05:08.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":1802,"price":217.5199,"value":391970.8598,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $217.01 to $218.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":138841,"source":{"system":"sec-edgar","filing":"0002010019-26-000015","document":"form4-06032026_090604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000015/form4-06032026_090604.xml","form_type":"4"}},{"id":760419,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-05-29T01:05:07.000Z","date":"2026-05-26","kind":"sale","planned":true,"acquired":false,"shares":1652,"price":202.8398,"value":335091.3496,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on June 10, 2022."}],"balance_after":140643,"source":{"system":"sec-edgar","filing":"0002010019-26-000014","document":"form4-05282026_090503.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000014/form4-05282026_090503.xml","form_type":"4"}},{"id":792074,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-05-06T01:35:11.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":150,"price":206.93,"value":31039.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."}],"balance_after":142295,"source":{"system":"sec-edgar","filing":"0002010019-26-000013","document":"form4-05052026_090506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000013/form4-05052026_090506.xml","form_type":"4"}},{"id":792073,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-05-06T01:35:11.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":400,"price":205.3075,"value":82123.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.19 to $205.56 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":142445,"source":{"system":"sec-edgar","filing":"0002010019-26-000013","document":"form4-05052026_090506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000013/form4-05052026_090506.xml","form_type":"4"}},{"id":792072,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-05-06T01:35:11.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":865,"price":204.4657,"value":176862.8305,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $204.17 to $205.05 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":142845,"source":{"system":"sec-edgar","filing":"0002010019-26-000013","document":"form4-05052026_090506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000013/form4-05052026_090506.xml","form_type":"4"}},{"id":792071,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-05-06T01:35:11.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":505,"price":203.3155,"value":102674.3275,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.00 to $203.81 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":143710,"source":{"system":"sec-edgar","filing":"0002010019-26-000013","document":"form4-05052026_090506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000013/form4-05052026_090506.xml","form_type":"4"}},{"id":792070,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-05-06T01:35:11.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":520,"price":201.6004,"value":104832.208,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.5200 to $20.6150 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":144215,"source":{"system":"sec-edgar","filing":"0002010019-26-000013","document":"form4-05052026_090506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000013/form4-05052026_090506.xml","form_type":"4"}},{"id":792069,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-05-06T01:35:11.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":560,"price":200.9523,"value":112533.288,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.31 to $201.23 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":144735,"source":{"system":"sec-edgar","filing":"0002010019-26-000013","document":"form4-05052026_090506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000013/form4-05052026_090506.xml","form_type":"4"}},{"id":792068,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-05-06T01:35:11.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":405,"price":206.16,"value":83494.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025."}],"balance_after":145295,"source":{"system":"sec-edgar","filing":"0002010019-26-000013","document":"form4-05052026_090506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000013/form4-05052026_090506.xml","form_type":"4"}},{"id":798072,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-04-30T01:35:10.000Z","date":"2026-04-27","kind":"sale","planned":true,"acquired":false,"shares":1185,"price":204.39,"value":242202.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023."}],"balance_after":145700,"source":{"system":"sec-edgar","filing":"0002010019-26-000012","document":"form4-04292026_090406.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000012/form4-04292026_090406.xml","form_type":"4"}},{"id":798071,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-04-30T01:35:10.000Z","date":"2026-04-27","kind":"sale","planned":true,"acquired":false,"shares":997,"price":203.75,"value":203138.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (\"RSUs\") and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 26, 2024."}],"balance_after":146885,"source":{"system":"sec-edgar","filing":"0002010019-26-000012","document":"form4-04292026_090406.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000012/form4-04292026_090406.xml","form_type":"4"}},{"id":817003,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-04-04T01:05:06.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":952,"price":203.3106,"value":193551.6912,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.08 to $203.51 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":147882,"source":{"system":"sec-edgar","filing":"0002010019-26-000011","document":"form4-04032026_090401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000011/form4-04032026_090401.xml","form_type":"4"}},{"id":817002,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-04-04T01:05:06.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":202.3638,"value":202363.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.0800 to $202.6150 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":148834,"source":{"system":"sec-edgar","filing":"0002010019-26-000011","document":"form4-04032026_090401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000011/form4-04032026_090401.xml","form_type":"4"}},{"id":817001,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-04-04T01:05:06.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":1048,"price":201.3206,"value":210983.9888,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.00 to $201.93 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":149834,"source":{"system":"sec-edgar","filing":"0002010019-26-000011","document":"form4-04032026_090401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000011/form4-04032026_090401.xml","form_type":"4"}},{"id":849062,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-03-11T22:05:05.000Z","date":"2026-03-10","kind":"sale","planned":true,"acquired":false,"shares":915,"price":204.1327,"value":186781.4205,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on March 9, 2026."}],"balance_after":150882,"source":{"system":"sec-edgar","filing":"0002010019-26-000008","document":"form4-03112026_060302.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000008/form4-03112026_060302.xml","form_type":"4"}},{"id":849061,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-03-11T22:05:05.000Z","date":"2026-03-09","kind":"grant","planned":true,"acquired":true,"shares":1774,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of Restricted Stock Units (\"RSUs\") to the Reporting Person. The RSUs were fully-vested at the time of issuance."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":151797,"source":{"system":"sec-edgar","filing":"0002010019-26-000008","document":"form4-03112026_060302.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000008/form4-03112026_060302.xml","form_type":"4"}},{"id":868584,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-04T02:05:04.000Z","date":"2026-03-02","kind":"exercise","planned":true,"acquired":false,"shares":5125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option shares are fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":9.59,"expiration_date":"2026-04-07","underlying":"Common Stock","underlying_shares":5125},"source":{"system":"sec-edgar","filing":"0002010019-26-000007","document":"form4-03032026_090301.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000007/form4-03032026_090301.xml","form_type":"4"}},{"id":868583,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-03-04T02:05:04.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":475,"price":200.9679,"value":95459.7525,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.72 to $201.16 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":150023,"source":{"system":"sec-edgar","filing":"0002010019-26-000007","document":"form4-03032026_090301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000007/form4-03032026_090301.xml","form_type":"4"}},{"id":868582,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-03-04T02:05:04.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":1594,"price":200.1073,"value":318971.0362,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.6750 to $200.5100 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":150498,"source":{"system":"sec-edgar","filing":"0002010019-26-000007","document":"form4-03032026_090301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000007/form4-03032026_090301.xml","form_type":"4"}},{"id":868581,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-03-04T02:05:04.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":931,"price":198.8338,"value":185114.2678,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.42 to $199.25 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":152092,"source":{"system":"sec-edgar","filing":"0002010019-26-000007","document":"form4-03032026_090301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000007/form4-03032026_090301.xml","form_type":"4"}},{"id":868580,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-03-04T02:05:04.000Z","date":"2026-03-02","kind":"exercise","planned":true,"acquired":true,"shares":5125,"price":9.59,"value":49148.75,"ownership":{"direct":true},"balance_after":153023,"source":{"system":"sec-edgar","filing":"0002010019-26-000007","document":"form4-03032026_090301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000007/form4-03032026_090301.xml","form_type":"4"}},{"id":868579,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-03-04T02:05:04.000Z","date":"2026-02-27","kind":"grant","planned":true,"acquired":true,"shares":10051,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of Restricted Stock Units (\"RSUs\") to the Reporting Person. The RSUs vest over four years. 25% of the RSUs vest on March 1, 2027 and the remaining RSUs vest in 12 equal quarterly installments thereafter."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":147898,"source":{"system":"sec-edgar","filing":"0002010019-26-000007","document":"form4-03032026_090301.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000007/form4-03032026_090301.xml","form_type":"4"}},{"id":919661,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-02-05T02:35:09.000Z","date":"2026-02-03","kind":"sale","planned":true,"acquired":false,"shares":1639,"price":230.768,"value":378228.752,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025."}],"balance_after":137847,"source":{"system":"sec-edgar","filing":"0002010019-26-000006","document":"form4-02042026_090205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000006/form4-02042026_090205.xml","form_type":"4"}},{"id":919660,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-02-05T02:35:09.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":16,"price":234,"value":3744.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."}],"balance_after":139486,"source":{"system":"sec-edgar","filing":"0002010019-26-000006","document":"form4-02042026_090205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000006/form4-02042026_090205.xml","form_type":"4"}},{"id":919659,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-02-05T02:35:09.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":600,"price":233.2367,"value":139942.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $232.94 to $233.82 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":139502,"source":{"system":"sec-edgar","filing":"0002010019-26-000006","document":"form4-02042026_090205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000006/form4-02042026_090205.xml","form_type":"4"}},{"id":919658,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-02-05T02:35:09.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":850,"price":232.3253,"value":197476.505,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $231.94 to $232.92 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":140102,"source":{"system":"sec-edgar","filing":"0002010019-26-000006","document":"form4-02042026_090205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000006/form4-02042026_090205.xml","form_type":"4"}},{"id":919657,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-02-05T02:35:09.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":576,"price":230.8399,"value":132963.7824,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.6150 to $231.1400 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":140952,"source":{"system":"sec-edgar","filing":"0002010019-26-000006","document":"form4-02042026_090205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000006/form4-02042026_090205.xml","form_type":"4"}},{"id":919656,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-02-05T02:35:09.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":878,"price":229.9577,"value":201902.8606,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $229.5700 to $230.5150 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":141528,"source":{"system":"sec-edgar","filing":"0002010019-26-000006","document":"form4-02042026_090205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000006/form4-02042026_090205.xml","form_type":"4"}},{"id":919655,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-02-05T02:35:09.000Z","date":"2026-02-02","kind":"sale","planned":true,"acquired":false,"shares":80,"price":228.5,"value":18280.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."}],"balance_after":142406,"source":{"system":"sec-edgar","filing":"0002010019-26-000006","document":"form4-02042026_090205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000006/form4-02042026_090205.xml","form_type":"4"}},{"id":928000,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-01-30T01:35:06.000Z","date":"2026-01-28","kind":"sale","planned":true,"acquired":false,"shares":1200,"price":237.6624,"value":285194.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023."}],"balance_after":142486,"source":{"system":"sec-edgar","filing":"0002010019-26-000005","document":"form4-01292026_080103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000005/form4-01292026_080103.xml","form_type":"4"}},{"id":927999,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-01-30T01:35:06.000Z","date":"2026-01-27","kind":"sale","planned":true,"acquired":false,"shares":1013,"price":240.5313,"value":243658.2069,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 26, 2024."}],"balance_after":143686,"source":{"system":"sec-edgar","filing":"0002010019-26-000005","document":"form4-01292026_080103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000005/form4-01292026_080103.xml","form_type":"4"}},{"id":933540,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-01-23T02:05:07.000Z","date":"2026-01-21","kind":"sale","planned":true,"acquired":false,"shares":293,"price":235,"value":68855.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 28, 2022."}],"balance_after":144699,"source":{"system":"sec-edgar","filing":"0002010019-26-000004","document":"form4-01222026_090103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000004/form4-01222026_090103.xml","form_type":"4"}},{"id":933539,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-01-23T02:05:07.000Z","date":"2026-01-20","kind":"sale","planned":true,"acquired":false,"shares":23205,"price":234.7384,"value":5447104.572,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs) and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023."}],"balance_after":144992,"source":{"system":"sec-edgar","filing":"0002010019-26-000004","document":"form4-01222026_090103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000004/form4-01222026_090103.xml","form_type":"4"}},{"id":937410,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-01-17T02:05:09.000Z","date":"2026-01-14","kind":"grant","planned":true,"acquired":true,"shares":44698,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 27, 2023, the Reporting Person was granted a performance-based Restricted Stock Unit (RSU) award which vests in tranches upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. On January 14, 2026, the performance threshold with respect to one milestone under the RSUs was certified, resulting in the vesting of 44,698 shares of Common Stock."}],"balance_after":168197,"source":{"system":"sec-edgar","filing":"0002010019-26-000003","document":"form4-01162026_090105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000003/form4-01162026_090105.xml","form_type":"4"}},{"id":947247,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-01-07T02:05:09.000Z","date":"2026-01-02","kind":"sale","planned":true,"acquired":false,"shares":1659,"price":229.4273,"value":380619.8907,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.94 to $229.73 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":123499,"source":{"system":"sec-edgar","filing":"0002010019-26-000002","document":"form4-01062026_090103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000002/form4-01062026_090103.xml","form_type":"4"}},{"id":947246,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2026-01-07T02:05:09.000Z","date":"2026-01-02","kind":"sale","planned":true,"acquired":false,"shares":1292,"price":228.3294,"value":295001.5848,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.8050 to $228.76 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":125158,"source":{"system":"sec-edgar","filing":"0002010019-26-000002","document":"form4-01062026_090103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001926000002/form4-01062026_090103.xml","form_type":"4"}},{"id":967899,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Stock Option (right to buy)","published_at":"2025-12-17T02:05:07.000Z","date":"2025-12-10","kind":"exercise","planned":false,"acquired":false,"shares":22376,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The options exercised were composed of 13,500 incentive stock options and 8,876 non-qualified stock options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option shares are fully exercisable."}],"balance_after":5125,"derivative":{"exercise_price":9.59,"expiration_date":"2026-04-07","underlying":"Common Stock","underlying_shares":22376},"source":{"system":"sec-edgar","filing":"0002010019-25-000016","document":"form4-12162025_091203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001925000016/form4-12162025_091203.xml","form_type":"4"}},{"id":967898,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-12-17T02:05:07.000Z","date":"2025-12-15","kind":"gift","planned":false,"acquired":false,"shares":115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a charitable contribution by the Reporting Person."}],"balance_after":126450,"source":{"system":"sec-edgar","filing":"0002010019-25-000016","document":"form4-12162025_091203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001925000016/form4-12162025_091203.xml","form_type":"4"}},{"id":967897,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-12-17T02:05:07.000Z","date":"2025-12-12","kind":"exercise","planned":false,"acquired":true,"shares":13500,"price":9.59,"value":129465.0,"ownership":{"direct":true},"balance_after":126565,"source":{"system":"sec-edgar","filing":"0002010019-25-000016","document":"form4-12162025_091203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001925000016/form4-12162025_091203.xml","form_type":"4"}},{"id":967896,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-12-17T02:05:07.000Z","date":"2025-12-12","kind":"sale","planned":false,"acquired":false,"shares":4692,"price":230.7575,"value":1082714.19,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale of these shares was effected in order to cover the exercise price and satisfy tax withholding and remittance obligations in connection with the exercise of expiring options."}],"balance_after":113065,"source":{"system":"sec-edgar","filing":"0002010019-25-000016","document":"form4-12162025_091203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001925000016/form4-12162025_091203.xml","form_type":"4"}},{"id":967895,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-12-17T02:05:07.000Z","date":"2025-12-12","kind":"exercise","planned":false,"acquired":true,"shares":8876,"price":9.59,"value":85120.84,"ownership":{"direct":true},"balance_after":117757,"source":{"system":"sec-edgar","filing":"0002010019-25-000016","document":"form4-12162025_091203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001925000016/form4-12162025_091203.xml","form_type":"4"}},{"id":967894,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-12-17T02:05:07.000Z","date":"2025-12-12","kind":"gift","planned":false,"acquired":false,"shares":180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a charitable contribution by the Reporting Person."}],"balance_after":108881,"source":{"system":"sec-edgar","filing":"0002010019-25-000016","document":"form4-12162025_091203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001925000016/form4-12162025_091203.xml","form_type":"4"}},{"id":981892,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-12-04T01:35:07.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":474,"price":239.5261,"value":113535.3714,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $239.44 to $239.64 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":109061,"source":{"system":"sec-edgar","filing":"0002010019-25-000014","document":"form4-12032025_081203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001925000014/form4-12032025_081203.xml","form_type":"4"}},{"id":981891,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-12-04T01:35:07.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":1527,"price":238.2428,"value":363796.7556,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.86 to $238.81 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":109535,"source":{"system":"sec-edgar","filing":"0002010019-25-000014","document":"form4-12032025_081203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001925000014/form4-12032025_081203.xml","form_type":"4"}},{"id":981890,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-12-04T01:35:07.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":250,"price":237.773,"value":59443.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.7550 to $237.7850 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":111062,"source":{"system":"sec-edgar","filing":"0002010019-25-000014","document":"form4-12032025_081203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001925000014/form4-12032025_081203.xml","form_type":"4"}},{"id":981889,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-12-04T01:35:07.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":749,"price":237.2275,"value":177683.3975,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $236.71 to $237.50 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":111312,"source":{"system":"sec-edgar","filing":"0002010019-25-000014","document":"form4-12032025_081203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001925000014/form4-12032025_081203.xml","form_type":"4"}},{"id":1008387,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-11-05T02:35:10.000Z","date":"2025-11-03","kind":"sale","planned":true,"acquired":false,"shares":100,"price":199.74,"value":19974.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."}],"balance_after":112061,"source":{"system":"sec-edgar","filing":"0002010019-25-000012","document":"form4-11042025_091102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001925000012/form4-11042025_091102.xml","form_type":"4"}},{"id":1008386,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-11-05T02:35:10.000Z","date":"2025-11-03","kind":"sale","planned":true,"acquired":false,"shares":1450,"price":199.1023,"value":288698.335,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.71 to $199.42 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":112161,"source":{"system":"sec-edgar","filing":"0002010019-25-000012","document":"form4-11042025_091102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001925000012/form4-11042025_091102.xml","form_type":"4"}},{"id":1008385,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-11-05T02:35:10.000Z","date":"2025-11-03","kind":"sale","planned":true,"acquired":false,"shares":1450,"price":198.026,"value":287137.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.28 to $198.26 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":113611,"source":{"system":"sec-edgar","filing":"0002010019-25-000012","document":"form4-11042025_091102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001925000012/form4-11042025_091102.xml","form_type":"4"}},{"id":1012135,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-10-30T01:05:07.000Z","date":"2025-10-28","kind":"sale","planned":true,"acquired":false,"shares":1198,"price":191.4619,"value":229371.3562,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023."}],"balance_after":115061,"source":{"system":"sec-edgar","filing":"0002010019-25-000010","document":"form4-10292025_091003.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001925000010/form4-10292025_091003.xml","form_type":"4"}},{"id":1012134,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-10-30T01:05:07.000Z","date":"2025-10-27","kind":"sale","planned":true,"acquired":false,"shares":1008,"price":192.324,"value":193862.592,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 26, 2024."}],"balance_after":116259,"source":{"system":"sec-edgar","filing":"0002010019-25-000010","document":"form4-10292025_091003.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001925000010/form4-10292025_091003.xml","form_type":"4"}},{"id":1014856,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-10-23T01:05:10.000Z","date":"2025-10-21","kind":"sale","planned":true,"acquired":false,"shares":292,"price":187.95,"value":54881.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 28, 2022."}],"balance_after":117267,"source":{"system":"sec-edgar","filing":"0002010019-25-000008","document":"form4-10222025_091006.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001925000008/form4-10222025_091006.xml","form_type":"4"}},{"id":1029568,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-10-02T01:35:12.000Z","date":"2025-10-01","kind":"sale","planned":true,"acquired":false,"shares":780,"price":160.7008,"value":125346.624,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $160.42 to $161.39 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":117559,"source":{"system":"sec-edgar","filing":"0002010019-25-000006","document":"form4-10012025_091008.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001925000006/form4-10012025_091008.xml","form_type":"4"}},{"id":1029567,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-10-02T01:35:12.000Z","date":"2025-10-01","kind":"sale","planned":true,"acquired":false,"shares":1816,"price":159.9131,"value":290402.1896,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.40 to $160.38 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":118339,"source":{"system":"sec-edgar","filing":"0002010019-25-000006","document":"form4-10012025_091008.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001925000006/form4-10012025_091008.xml","form_type":"4"}},{"id":1029566,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-10-02T01:35:12.000Z","date":"2025-10-01","kind":"sale","planned":true,"acquired":false,"shares":404,"price":158.9606,"value":64220.0824,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.39 to $159.2950 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":120155,"source":{"system":"sec-edgar","filing":"0002010019-25-000006","document":"form4-10012025_091008.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001925000006/form4-10012025_091008.xml","form_type":"4"}},{"id":1038142,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-09-18T00:05:04.000Z","date":"2025-09-15","kind":"gift","planned":false,"acquired":false,"shares":300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a charitable contribution by the Reporting Person."}],"balance_after":120559,"source":{"system":"sec-edgar","filing":"0002010019-25-000003","document":"form4-09172025_080901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000201001925000003/form4-09172025_080901.xml","form_type":"4"}},{"id":1046960,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-09-06T01:05:05.000Z","date":"2025-09-02","kind":"sale","planned":true,"acquired":false,"shares":1210,"price":167.7145,"value":202934.545,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.41 to $168.21 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":120859,"source":{"system":"sec-edgar","filing":"0001415889-25-023825","document":"form4-09052025_090901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000141588925023825/form4-09052025_090901.xml","form_type":"4"}},{"id":1046959,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-09-06T01:05:05.000Z","date":"2025-09-02","kind":"sale","planned":true,"acquired":false,"shares":500,"price":166.39,"value":83195.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.09 to $166.60 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":122069,"source":{"system":"sec-edgar","filing":"0001415889-25-023825","document":"form4-09052025_090901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000141588925023825/form4-09052025_090901.xml","form_type":"4"}},{"id":1046958,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-09-06T01:05:05.000Z","date":"2025-09-02","kind":"sale","planned":true,"acquired":false,"shares":1290,"price":165.6862,"value":213735.198,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.09 to $166.06 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":122569,"source":{"system":"sec-edgar","filing":"0001415889-25-023825","document":"form4-09052025_090901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000141588925023825/form4-09052025_090901.xml","form_type":"4"}},{"id":1065529,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-08-16T01:35:06.000Z","date":"2025-08-14","kind":"sale","planned":true,"acquired":false,"shares":8,"price":155.4248,"value":1243.3984,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on October 22, 2021."}],"balance_after":123859,"source":{"system":"sec-edgar","filing":"0001415889-25-022148","document":"form4-08152025_090803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000141588925022148/form4-08152025_090803.xml","form_type":"4"}},{"id":1065528,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-08-16T01:35:06.000Z","date":"2025-08-14","kind":"sale","planned":true,"acquired":false,"shares":867,"price":155.46,"value":134783.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on October 22, 2021."}],"balance_after":123867,"source":{"system":"sec-edgar","filing":"0001415889-25-022148","document":"form4-08152025_090803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000141588925022148/form4-08152025_090803.xml","form_type":"4"}},{"id":1065527,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-08-16T01:35:06.000Z","date":"2025-08-12","kind":"grant","planned":true,"acquired":true,"shares":1675,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 22, 2021, the Reporting Person was granted Restricted Stock Units (\"RSUs\") covering 10,000 shares of Common Stock which vest in tranches upon the achievement of certain milestones relating to a combination of the passage of time and certain business performance criteria. On August 12, 2025, the achievement of criteria was certified for the vesting of RSUs covering 1,675 shares of Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":124734,"source":{"system":"sec-edgar","filing":"0001415889-25-022148","document":"form4-08152025_090803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000141588925022148/form4-08152025_090803.xml","form_type":"4"}},{"id":1074964,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-08-06T01:05:05.000Z","date":"2025-08-01","kind":"sale","planned":true,"acquired":false,"shares":100,"price":134.08,"value":13408.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."}],"balance_after":123059,"source":{"system":"sec-edgar","filing":"0001415889-25-021139","document":"form4-08052025_090801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000141588925021139/form4-08052025_090801.xml","form_type":"4"}},{"id":1074963,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-08-06T01:05:05.000Z","date":"2025-08-01","kind":"sale","planned":true,"acquired":false,"shares":1326,"price":133.3097,"value":176768.6622,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.96 to $133.80 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":123159,"source":{"system":"sec-edgar","filing":"0001415889-25-021139","document":"form4-08052025_090801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000141588925021139/form4-08052025_090801.xml","form_type":"4"}},{"id":1074962,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-08-06T01:05:05.000Z","date":"2025-08-01","kind":"sale","planned":true,"acquired":false,"shares":1574,"price":132.4528,"value":208480.7072,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.9350 to $132.78 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":124485,"source":{"system":"sec-edgar","filing":"0001415889-25-021139","document":"form4-08052025_090801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000141588925021139/form4-08052025_090801.xml","form_type":"4"}},{"id":1079259,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-07-31T01:35:09.000Z","date":"2025-07-28","kind":"sale","planned":true,"acquired":false,"shares":2206,"price":139.8083,"value":308417.1098,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 27, 2023 and January 26, 2024."}],"balance_after":126059,"source":{"system":"sec-edgar","filing":"0001415889-25-020663","document":"form4-07302025_090705.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000141588925020663/form4-07302025_090705.xml","form_type":"4"}},{"id":1083533,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-07-23T01:05:07.000Z","date":"2025-07-21","kind":"sale","planned":true,"acquired":false,"shares":291,"price":139.29,"value":40533.39,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 28, 2022."}],"balance_after":128265,"source":{"system":"sec-edgar","filing":"0001415889-25-020156","document":"form4-07222025_090703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000141588925020156/form4-07222025_090703.xml","form_type":"4"}},{"id":1083532,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-07-23T01:05:07.000Z","date":"2025-05-27","kind":"sale","planned":true,"acquired":false,"shares":1649,"price":156.8505,"value":258646.4745,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on June 10, 2022."}],"balance_after":128556,"source":{"system":"sec-edgar","filing":"0001415889-25-020156","document":"form4-07222025_090703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000141588925020156/form4-07222025_090703.xml","form_type":"4"}},{"id":1092814,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-07-04T01:05:06.000Z","date":"2025-07-01","kind":"sale","planned":true,"acquired":false,"shares":291,"price":167.79,"value":48826.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."}],"balance_after":130205,"source":{"system":"sec-edgar","filing":"0001415889-25-019390","document":"form4-07032025_090703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000141588925019390/form4-07032025_090703.xml","form_type":"4"}},{"id":1092813,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-07-04T01:05:06.000Z","date":"2025-07-01","kind":"sale","planned":true,"acquired":false,"shares":2109,"price":167.2501,"value":352730.4609,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.64 to $167.60 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":130496,"source":{"system":"sec-edgar","filing":"0001415889-25-019390","document":"form4-07032025_090703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000141588925019390/form4-07032025_090703.xml","form_type":"4"}},{"id":1092812,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-07-04T01:05:06.000Z","date":"2025-07-01","kind":"sale","planned":true,"acquired":false,"shares":200,"price":165.985,"value":33197.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.62 to $166.35 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":132605,"source":{"system":"sec-edgar","filing":"0001415889-25-019390","document":"form4-07032025_090703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000141588925019390/form4-07032025_090703.xml","form_type":"4"}},{"id":1092811,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-07-04T01:05:06.000Z","date":"2025-07-01","kind":"sale","planned":true,"acquired":false,"shares":400,"price":163.8764,"value":65550.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.55 to $164.08 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":132805,"source":{"system":"sec-edgar","filing":"0001415889-25-019390","document":"form4-07032025_090703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000141588925019390/form4-07032025_090703.xml","form_type":"4"}},{"id":1123219,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-06-05T01:05:06.000Z","date":"2025-06-02","kind":"sale","planned":true,"acquired":false,"shares":100,"price":159.12,"value":15912.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."}],"balance_after":133205,"source":{"system":"sec-edgar","filing":"0001415889-25-015716","document":"form4-06042025_090603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000141588925015716/form4-06042025_090603.xml","form_type":"4"}},{"id":1123218,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-06-05T01:05:06.000Z","date":"2025-06-02","kind":"sale","planned":true,"acquired":false,"shares":465,"price":158.3718,"value":73642.887,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.88 to $158.5450 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":133305,"source":{"system":"sec-edgar","filing":"0001415889-25-015716","document":"form4-06042025_090603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000141588925015716/form4-06042025_090603.xml","form_type":"4"}},{"id":1123217,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-06-05T01:05:06.000Z","date":"2025-06-02","kind":"sale","planned":true,"acquired":false,"shares":1145,"price":157.2298,"value":180028.121,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.74 to $157.54 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":133770,"source":{"system":"sec-edgar","filing":"0001415889-25-015716","document":"form4-06042025_090603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000141588925015716/form4-06042025_090603.xml","form_type":"4"}},{"id":1123216,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-06-05T01:05:06.000Z","date":"2025-06-02","kind":"sale","planned":true,"acquired":false,"shares":1290,"price":156.3016,"value":201629.064,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.73 to $156.69 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":134915,"source":{"system":"sec-edgar","filing":"0001415889-25-015716","document":"form4-06042025_090603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000141588925015716/form4-06042025_090603.xml","form_type":"4"}},{"id":1161366,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-05-03T01:35:07.000Z","date":"2025-05-01","kind":"sale","planned":true,"acquired":false,"shares":331,"price":152.04,"value":50325.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."}],"balance_after":136205,"source":{"system":"sec-edgar","filing":"0001415889-25-011882","document":"form4-05022025_090504.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000141588925011882/form4-05022025_090504.xml","form_type":"4"}},{"id":1161365,"issuer":{"id":2635,"kind":"organization","name":"Natera, Inc.","symbol":"NTRA"},"owners":[{"id":2653,"kind":"person","name":"Moshkevich Solomon","position":1,"cik":"0002010019","reported_name":"Moshkevich Solomon","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT, CLINICALDIAGNOSTICS"}}],"security":"Common Stock","published_at":"2025-05-03T01:35:07.000Z","date":"2025-05-01","kind":"sale","planned":true,"acquired":false,"shares":908,"price":151.2984,"value":137378.9472,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.97 to $151.5450 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":136536,"source":{"system":"sec-edgar","filing":"0001415889-25-011882","document":"form4-05022025_090504.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2010019/000141588925011882/form4-05022025_090504.xml","form_type":"4"}}],"next_cursor":"2025-05-03T01:35:07.000000Z,1161365"}